The next steps and clinical implications for Wnt signalling for the treatment of melanoma
The toxicities associated with immunotherapy in lung cancer patients
Mechanisms of resistance to checkpoint inhibitors in melanoma
What support can doctors provide patients in terms of pyschological well-being?
Treatment options for stage III melanoma patients